Medtronic Receives Health Canada Licence for the First Insulin Pump System that Automatically Adjusts Basal Insulin for People Living with Type 1 Diabetes
Sunday, 21 October 2018
Medtronic of Canada Ltd., a subsidiary of Medtronic plc (NYSE: MDT), today announced it has received a licence from Health Canada for the MiniMed™ 670G system — the first insulin pump system in Canada that helps to stabilize glucose levels 24 hours a day by automatically adjusting basal insulin delivery based on real-time insulin needs.
- Published in Health & life sciences
No Comments